CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
SRRK Scholar Rock
- 32.910
- +0.150+0.46%
Close May 2 16:00 ET
- 32.910
- 0.0000.00%
Post 16:20 ET
3.12BMarket Cap-13.32P/E (TTM)
33.480High32.100Low1.34MVolume33.000Open32.760Pre Close43.85MTurnover2.12%Turnover RatioLossP/E (Static)94.86MShares46.98052wk High8.47P/B2.08BFloat Cap6.76052wk Low--Dividend TTM63.31MShs Float70.000Historical High--Div YieldTTM4.21%Amplitude4.325Historical Low32.742Avg Price1Lot Size
About Scholar Rock Company
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Company Profile
SymbolSRRK
Company NameScholar Rock
Listing DateMay 24, 2018
Issue Price14.00
Founded2012
CEOMr. David L. Hallal
MarketNASDAQ
Employees196
Fiscal Year Ends12-31
Address301 Binney Street,3rd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-259-3860
Websitehttp://www.scholarrock.com
Company Executives
- Name
- Position
- Salary
- David L. Hallal
- Chairman of the Board and Chief Executive Officer
- 400.85K
- Lisa Wyman
- Chief Technical and Quality Officer
- --
- Tracey Sacco
- Chief Commercial Officer
- --
- Caryn Parlavecchio
- Chief Human Resources Officer
- --
- Beth Shafer, PhD
- Chief Business Officer
- --
- Mohammed Qatanani, PhD
- Chief Scientific Officer
- 2.96M
- Dr. Jing L. Marantz, M.D.,PhD
- Chief Medical Officer
- 3.08M
- Vikas Sinha
- Chief Financial Officer
- --
- Robert Keith Woods
- Chief Operating Officer
- --
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Director and President, Research and Development
- 281.26K
- Kristina M. Burow
- Independent Director
- 282.94K
- Katie Peng
- Independent Director
- 918.84K
- Richard H. Brudnick
- Independent Director
- 278.76K
- Michael Gilman, PhD
- Independent Director
- 283.35K
- Joshua Reed
- Independent Director
- 288.76K
- Dr. Srinivas Akkaraju, M.D.,PhD
- Independent Director
- 276.26K
- Dr. Jeffrey S. Flier, M.D.
- Independent Director
- 288.76K
- Junlin Ho, J.D.
- General Counsel and Corporate Secretary
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀